Catalyst Wire Dossier Catalyst Wire Dossier

entre ctinib

entrectinib · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for entre ctinib, covering 2020-03-09 to 2020-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects [Phase 1]

See pricing